130 related articles for article (PubMed ID: 19639202)
1. Up-regulation of hTERT expression by low-dose cisplatin contributes to chemotherapy resistance in human hepatocellular cancer cells.
Guo XL; Ma NN; Zhou FG; Zhang L; Bu XX; Sun K; Song JR; Li R; Zhang BH; Wu MC; Wei LX
Oncol Rep; 2009 Sep; 22(3):549-56. PubMed ID: 19639202
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096
[TBL] [Abstract][Full Text] [Related]
3. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D
Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030
[TBL] [Abstract][Full Text] [Related]
4. Human telomerase reverse transcriptase (hTERT): a target molecule for the treatment of cisplatin-resistant tumors.
Park YP; Kim KD; Kang SH; Yoon DY; Park JW; Kim JW; Lee HG
Korean J Lab Med; 2008 Dec; 28(6):430-7. PubMed ID: 19127107
[TBL] [Abstract][Full Text] [Related]
5. NF-kappaB p65 modulates the telomerase reverse transcriptase in the HepG₂ hepatoma cell line.
Zuo QP; Liu SK; Li ZJ; Li B; Zhou YL; Guo R; Huang LH
Eur J Pharmacol; 2011 Dec; 672(1-3):113-20. PubMed ID: 22008847
[TBL] [Abstract][Full Text] [Related]
6. Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1.
Wirth T; Kühnel F; Fleischmann-Mundt B; Woller N; Djojosubroto M; Rudolph KL; Manns M; Zender L; Kubicka S
Cancer Res; 2005 Aug; 65(16):7393-402. PubMed ID: 16103092
[TBL] [Abstract][Full Text] [Related]
7. The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer.
Sun PM; Wei LH; Luo MY; Liu G; Wang JL; Mustea A; Könsgen D; Lichtenegger W; Sehouli J
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):249-57. PubMed ID: 16519988
[TBL] [Abstract][Full Text] [Related]
8. Human telomerase reverse transcriptase regulates MMP expression independently of telomerase activity via NF-κB-dependent transcription.
Ding D; Xi P; Zhou J; Wang M; Cong YS
FASEB J; 2013 Nov; 27(11):4375-83. PubMed ID: 23884427
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells.
Dong X; Liu F; Li M
Anticancer Drugs; 2016 Apr; 27(4):286-99. PubMed ID: 26704389
[TBL] [Abstract][Full Text] [Related]
10. siRNA-mediated inhibition of hTERT enhances chemosensitivity of hepatocellular carcinoma.
Guo X; Wang W; Zhou F; Lu Z; Fang R; Jia F; Bu X; Li R; Zhang B; Wu M; Wei L
Cancer Biol Ther; 2008 Oct; 7(10):1555-60. PubMed ID: 18708758
[TBL] [Abstract][Full Text] [Related]
11. Modulation of human telomerase reverse transcriptase in hepatocellular carcinoma.
Chen CJ; Kyo S; Liu YC; Cheng YL; Hsieh CB; Chan DC; Yu JC; Harn HJ
World J Gastroenterol; 2004 Mar; 10(5):638-42. PubMed ID: 14991929
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ
Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
[TBL] [Abstract][Full Text] [Related]
13. The effect of natural polyphenols Resveratrol, Gallic acid, and Kuromanin chloride on human telomerase reverse transcriptase (hTERT) expression in HepG2 hepatocellular carcinoma: role of SIRT1/Nrf2 signaling pathway and oxidative stress.
Moghadam D; Zarei R; Vakili S; Ghojoghi R; Zarezade V; Veisi A; Sabaghan M; Azadbakht O; Behrouj H
Mol Biol Rep; 2023 Jan; 50(1):77-84. PubMed ID: 36307623
[TBL] [Abstract][Full Text] [Related]
14. Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells.
Zhang RG; Zhang RP; Wang XW; Xie H
Cell Res; 2002 Mar; 12(1):55-62. PubMed ID: 11942411
[TBL] [Abstract][Full Text] [Related]
15. Change of the expression of human telomerase reverse transcriptase mRNA and human telomerase RNA after cisplatin and 5-fluorouracil exposure in head and neck squamous cell carcinoma cell lines.
Lee BJ; Lee BH; Wang SG; Lee JC; Roh HJ; Goh EK; Kim CM; Jun ES
J Korean Med Sci; 2007 Sep; 22 Suppl(Suppl):S73-8. PubMed ID: 17923759
[TBL] [Abstract][Full Text] [Related]
16. Role of mitochondrial translocation of telomerase in hepatocellular carcinoma cells with multidrug resistance.
Ling X; Wen L; Zhou Y
Int J Med Sci; 2012; 9(7):545-54. PubMed ID: 22991493
[TBL] [Abstract][Full Text] [Related]
17. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
[TBL] [Abstract][Full Text] [Related]
18. The role of NF-kappaB in hepatocellular carcinoma cell.
Wang J; Huang Q; Chen M
Chin Med J (Engl); 2003 May; 116(5):747-52. PubMed ID: 12875694
[TBL] [Abstract][Full Text] [Related]
19. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma.
Takuma Y; Nouso K; Kobayashi Y; Nakamura S; Tanaka H; Matsumoto E; Fujikawa T; Suzuki M; Hanafusa T; Shiratori Y
J Gastroenterol Hepatol; 2004 Nov; 19(11):1300-4. PubMed ID: 15482538
[TBL] [Abstract][Full Text] [Related]
20. Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma.
Nagao K; Tomimatsu M; Endo H; Hisatomi H; Hikiji K
J Gastroenterol; 1999 Feb; 34(1):83-7. PubMed ID: 10204615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
